Karen Carroll

Micheal Binns

Karen Carroll a partner in Parker Poe’s Life Sciences Industry Team. Based in Atlanta, her practice focuses on pharmaceutical and biotechnology-related patent litigation and counseling. Prior to her legal career, Karen worked for more than 10 years in the biopharmaceutical industry, first as a research scientist at the Department of Neuropathology at Johns Hopkins University and Codon Pharmaceuticals, and then as a patent agent at Human Genome Sciences Inc.

For more information or to contact Karen, please visit her Firm Profile Page.

Posts by Karen Carroll

Recent USPTO Update Provides Blueprint for PTAB Patent Challenge Process

Since the passing of the America Invents Act (AIA) and the implementation of the inter partes review (IPR) process, IPR has become a popular and important avenue …

Post-Myriad Legal and Policy Considerations for Patenting Genetic Inventions

The U.S. Supreme Court’s 2013 ruling in Association for Molecular Pathology v. Myriad Genetics changed the landscape of what is considered patentable material in the context …

The Evolution of Antibody Patents

As the pharmaceutical industry continues to shift toward biologic-based drugs, including monoclonal antibodies, protecting the underlying technology has been and continues to be a priority for companies. …